Alexander Alanine, Chief Operating Officer Bactevo Vivek K Vishnudas, Chief Technology Officer Berg Health Thomas Franch, Chief Scientific Officer Nuevolution Thorsten Thormann, Senior Vice President New Product Discovery LEO Pharma Anna Maroney, Vice President, Head of Alliance Management AbbVie Yolanda Chong, Vice President Biology Recursion Pharmaceuticals Juergen Gamer, Vice President Business Development Apogenix Philip Tagari, Vice President Research Amgen Petre Vachal, Vice President Discovery Chemistry Merck Hubert Haag, Director Lead Discovery – Global Sourcing & External Business Opportunities Sanofi Mike Hann, GSK Senior Fellow & Director, Drug Design & Selection GlaxoSmithKline Rob Howes, Director Reagents and Assay Development, Discovery Sciences AstraZeneca Malin Lemurell, Director of Medicinal Chemistry AstraZeneca Matt Lucas, Director of Chemistry Yumanity Therapeutics Wei-Sheng Huang, Director of Discovery Chemistry Takeda Daniel Zwilling, Director of CNS Discovery Circuit Therapeutics Jose Duca, Head, Computer-Aided Drug Discovery Novartis Ulrich Schopfer, Head Integrated Target and Lead Discovery Novartis Christoph Dumelin, Laboratory Head Novartis Florian Fuchs, CBT Screening Sciences, Head Cellular Assays Novartis Gerhard Hessler, Head of Computational and Structural Drug Design Sanofi Tobias Gabriel, Head External Drug Discovery Novartis Lutz Mueller, Expert Toxicology Project Leader F. Hoffmann-La Roche Hasane Ratni, Senior Principal Scientist F. Hoffmann-La Roche Mike Morrison, Principal Scientist Epizyme Anthony Donofrio, Senior Scientist HTE and Lead Discovery Capabilities Merck Steve Andrews, Head of Chemistry Cambridge Drug Discovery Institute Paul Andrews, Director of Operations, National Phenotypic Screening Centre University of Dundee Rod Hubbard, Senior Fellow and Professor Vernalis and University of York Ernesto Freire, Henry Walters Professor Johns Hopkins University
|